Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enveric Biosciences Inc
(NQ:
ENVB
)
0.5180
+0.0280 (+5.71%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Dow Tumbles 150 Points; Alibaba Earnings Top Views
May 18, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.48% to 33,259.03 while the NASDAQ rose 0.63% to 12,579.41. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 18, 2023
Via
Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 18, 2023
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility.
Via
Benzinga
Enveric Biosciences Inc. (NASDAQ: ENVB) is One of Thursday Morning’s Most Active Stocks
May 18, 2023
Via
Investor Brand Network
Nasdaq Surges 100 Points; Walmart Raises Full-Year Outlook
May 18, 2023
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.09% to 33,451.95 while the NASDAQ rose 0.79% to 12,599.66. The S&P...
Via
Benzinga
Enveric Biosciences (NASDAQ: ENVB) Obtains Notice of Allowance For a U.S. Patent Covering Its Innovative Psilocin Prodrug, EB-373
May 18, 2023
Enveric Biosciences, Inc. (NASDAQ: ENVB) is engaged as a biotechnology company, which focused on the research and development of innovative
Via
Spotlight Growth
Topics
Derivatives
Intellectual Property
Exposures
Derivatives
Intellectual Property
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 18, 2023
Via
Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th
Via
Benzinga
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
May 18, 2023
From
Enveric Biosciences, Inc.
Via
Business Wire
Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
May 15, 2023
Enveric Biosciences, Inc. (NASDAQ: ENVB) released its corporate update and reported financial results for the first quarter of 2023 ending March 31, 2023.
Via
Benzinga
Enveric Biosciences Reports First Quarter 2023 Financial Results and Operational Highlights
May 15, 2023
From
Enveric Biosciences, Inc.
Via
Business Wire
Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month
May 02, 2023
From
Enveric Biosciences, Inc.
Via
Business Wire
EXCLUSIVE: Fireside With Enveric Biosciences's Dr. Tucker, Unlocking Psychedelic Healing Benefits
April 20, 2023
Recently, at the Benzinga Psychedelic Capital Conference, leading experts from the biotech and pharmaceutical industry gathered to discuss the remarkable potential of psychedelics in medicine.
Via
Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutionizing psychedelic therapy as a promising new approach for treating mental...
Via
Benzinga
Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference
April 10, 2023
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
April 03, 2023
From
Enveric Biosciences, Inc.
Via
Business Wire
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry
April 03, 2023
The world of psychedelics is evolving rapidly, and the Benzinga Psychedelics Capital Conference is the premier event for those who want to be part of this exciting journey.
Via
Benzinga
Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
March 27, 2023
Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses
Via
Benzinga
Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373
March 23, 2023
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications
March 21, 2023
From
Enveric Biosciences
Via
Business Wire
Enveric Creates Subsidiary Down Under To Further Next-Generation Psychedelics Program
March 21, 2023
Drug development biotech company Enveric Biosciences (NASDAQ: ENVB) has created Australia-based subsidiary Enveric Therapeutics Pty. Ltd. to support the progress of its next-generation psychedelics...
Via
Benzinga
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
March 20, 2023
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered
Via
Benzinga
Enveric Biosciences: Novel Next-Gen Drug Discovery Platform Includes Rare Toad Enzyme
March 14, 2023
Biopharma company Enveric Biosciences (NASDAQ: ENVB) has shared new findings involving the first-ever isolation of a specific enzyme from the cane toad, plus the successful development of a...
Via
Benzinga
Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery
March 14, 2023
From
Enveric Biosciences
Via
Business Wire
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Who's Who At The Benzinga Psychedelics Capital Conference? Check Out These CEOs & Meet Them In Person
March 08, 2023
This year’s edition of the Benzinga Psychedelics Capital Conference, THE place to be for those interested or already involved in the space, will take place on April 13, following our established...
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 23, 2023
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference
February 22, 2023
From
Enveric Biosciences
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.